leader olopatadine hydrochloride

Generic: olopatadine hydrochloride

Labeler: cardinal health
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name leader olopatadine hydrochloride
Generic Name olopatadine hydrochloride
Labeler cardinal health
Dosage Form SOLUTION
Routes
OPHTHALMIC
Active Ingredients

olopatadine hydrochloride 2 mg/mL

Manufacturer
CARDINAL HEALTH

Identifiers & Regulatory

Product NDC 70000-0716
Product ID 70000-0716_32c153a7-d51f-72c5-e063-6294a90aee29
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA206087
Listing Expiration 2026-12-31
Marketing Start 2025-04-15

Pharmacologic Class

Classes
decreased histamine release [pe] histamine h1 receptor antagonists [moa] histamine-1 receptor antagonist [epc] histamine-1 receptor inhibitor [epc] mast cell stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 700000716
Hyphenated Format 70000-0716

Supplemental Identifiers

RxCUI
1111343
UNII
2XG66W44KF

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name leader olopatadine hydrochloride (source: ndc)
Generic Name olopatadine hydrochloride (source: ndc)
Application Number ANDA206087 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (70000-0716-1) / 3.5 mL in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

Ingredients (1)

olopatadine hydrochloride (2 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "32c153a7-d51f-72c5-e063-6294a90aee29", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111343"], "spl_set_id": ["71d922d2-22a5-4103-a3eb-126094ee8ef5"], "manufacturer_name": ["CARDINAL HEALTH"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (70000-0716-1)  / 3.5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "70000-0716-1", "marketing_start_date": "20250415"}], "brand_name": "LEADER OLOPATADINE HYDROCHLORIDE", "product_id": "70000-0716_32c153a7-d51f-72c5-e063-6294a90aee29", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "70000-0716", "generic_name": "OLOPATADINE HYDROCHLORIDE", "labeler_name": "CARDINAL HEALTH", "product_type": "HUMAN OTC DRUG", "brand_name_base": "LEADER OLOPATADINE HYDROCHLORIDE", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA206087", "marketing_category": "ANDA", "marketing_start_date": "20250415", "listing_expiration_date": "20261231"}